Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00044213 · ClinicalTrials.gov registry record · Phase 3
Trial to Assess Chelation Therapy (TACT)
A Phase 3 study, sponsored by Mt. Sinai Medical Center, Miami.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,708
- Enrollment target
NCT00044213: Completed Phase 3 study, sponsored by Mt. Sinai Medical Center, Miami.
NCT00044213 is a Phase 3 study that has completed, run by Mt. Sinai Medical Center, Miami. The registered enrollment target is 1,708 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (121% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00044213, a Phase 3 study, has completed, sponsored by Mt. Sinai Medical Center, Miami.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,708 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the safety and effectiveness of ethylene diamine tetra-acetic (EDTA) chelation therapy in individuals with coronary artery disease.
Primary Outcome
Number of patients with events (composite of death from any cause, MI, stroke, coronary revascularization or hospitalization for angina) Events were centrally adjudicated where available; otherwise site reported events were used.
Interventions
- DRUG EDTA
- DRUG EDTA Placebo
- DIETARY_SUPPLEMENT High Dose Vitamin
- DIETARY_SUPPLEMENT High Dose Vitamin Placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,708 participants |
| Start Date | 2003-09 |
| Est. Completion | 2012-08 |
| Phase | Phase 3 |
What the finished NCT00044213 record still lists
NCT00044213 is an interventional study that assigns participants to a tested intervention. Its 1,708 participants enrollment target places it among the larger protocols in the corpus, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (121% higher).
The record links to 0 conditions, and to 4 interventions - of which EDTA is the first listed.
NCT00044213 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00044213 about?
NCT00044213 is a clinical study titled "Trial to Assess Chelation Therapy (TACT)". The purpose of this study is to determine the safety and effectiveness of ethylene diamine tetra-acetic (EDTA) chelation therapy in individuals with coronary artery disease.
What is the current status of trial NCT00044213?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,708 participants. The study started on 2003-09. Estimated completion is 2012-08.
What interventions are being tested in trial NCT00044213?
The interventions under investigation include: EDTA (DRUG), EDTA Placebo (DRUG), High Dose Vitamin (DIETARY_SUPPLEMENT), High Dose Vitamin Placebo (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00044213?
This trial is sponsored by Mt. Sinai Medical Center, Miami, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00044213's enrollment target sits among peer trials
1,708 132nd of 2000 higher than 1,869 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05303636 · 1,710 participants · Phase 4
LF111 or Drospirenone Chew vs Non-hormonal Contraceptive Methods on Bone Mineral Density in Adolescent and Adult Women
- NCT07304531 · 1,705 participants
First To Know Pregnancy Test - Clinical Evaluation Protocol
- NCT04291612 · 1,715 participants
Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease
- NCT04321200 · 1,700 participants
PANDA Gym: Automated Assessment of Neurodevelopment in Infants at Risk for Motor Disability
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia